Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 066501/0995 | |
| Pages: | 3 |
| | Recorded: | 02/20/2024 | | |
| Attorney Dkt #: | 150415.00015.US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17253927
|
Filing Dt:
|
12/18/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/02/2021
| | | | |
|
Title:
|
ONCOLYTIC VIRUS OR ANTIGEN PRESENTING CELL MEDIATED CANCER THERAPY USING TYPE I INTERFERON AND CD40-LIGAND
|
|
|
Assignee
|
|
|
|
|
| 12 GREENWAY PLAZA, SUITE 1100 |
| HOUSTON, TEXAS 77046 |
|
|
Correspondence name and address
|
| |
LEISA TALBERT PESCHEL
|
| |
HOUSTON IP DEPARTMENT
|
| |
1401 MCKINNEY ST., SUITE 1900
|
| |
HOUSTON, TX 77010
|
Search Results as of:
06/19/2024 11:06 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
